| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-07-20 | SCHEDULE 13D/A | ORBIMED ADVISORS LLC | — | 4,127,987 | view → |
| 2026-06-04 | SCHEDULE 13G | BIOTECHNOLOGY VALUE FUND L P | — | — | view → |
| 2026-06-01 | SCHEDULE 13D/A | ORBIMED ADVISORS LLC | — | 4,127,987 | view → |
| 2026-05-28 | SCHEDULE 13D/A | Atlas Venture Fund X, L.P. | 3.60% | 864,261 | view → |
| 2020-04-20 | SC | Flynn James E | — | — | view → |
| 2020-01-31 | SC | Flynn James E | — | — | view → |
| 2019-12-30 | SC | Flynn James E | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2024-11-18 | SC | iTeos Therapeutics, Inc. | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →